Two Sigma Investments’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.6M Sell
101,879
-45,420
-31% -$1.36M ﹤0.01% 2819
2026
Q2
$3.89M Sell
147,299
-68,800
-32% -$1.59M ﹤0.01% 2386
2026
Q1
$4.86M Sell
216,099
-84,318
-28% -$1.56M ﹤0.01% 2000
2025
Q4
$2.5M Buy
140,317
+23,738
+20% +$299K ﹤0.01% 2285
2025
Q3
$469K Buy
116,579
+71,844
+161% +$238K ﹤0.01% 3013
2025
Q2
$98.4K Buy
44,735
+18,593
+71% +$44.2K ﹤0.01% 3001
2025
Q1
$56.5K Sell
26,142
-4,558
-15% -$16.3K ﹤0.01% 3033
2024
Q4
$130K Buy
30,700
+17,760
+137% +$111K ﹤0.01% 2937
2024
Q3
$148K Buy
+12,940
New +$158K ﹤0.01% 2847

Other funds holding ANRO

Two Sigma Investments's ANRO Position: Q3 2026 in Review

Two Sigma Investments reduced its Alto Neuroscience (ANRO) stake by 31% in Q3 2026, selling an estimated $1.36M and leaving 101,879 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2819.

Two Sigma Investments first reported a position in ANRO in Q3 2024 and has held it in 9 quarters since. The position peaked at $4.86M in Q1 2026. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • Two Sigma Investments held 101,879 shares of Alto Neuroscience worth $2.6M as of Q3 2026.
  • Two Sigma Investments sold 45,420 Alto Neuroscience shares in Q3 2026, an estimated $1.36M.
  • Alto Neuroscience made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #2819 holding.
  • Two Sigma Investments first reported a position in Alto Neuroscience in Q3 2024 and has held it in 9 quarters since.
  • Two Sigma Investments's Alto Neuroscience position peaked at $4.86M in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.